TMCI241220C20000
- 0.10
- 0.000.00%
Treace Medical Concepts Newsroom
Treace Announces First Cases Utilizing RedPoint Intelliguide Patient Specific Instrumentation With the Adductoplasty System for Correction of Midfoot Deformities
Press Release: Treace Appoints Guy Guglielmino as Chief Commercial Officer
Express News | Treace Appoints Guy Guglielmino as Chief Commercial Officer
Treace Announces Participation at Stifel 2024 Healthcare Conference
US$7.50 - That's What Analysts Think Treace Medical Concepts, Inc. (NASDAQ:TMCI) Is Worth After These Results
Treace Medical Concepts Third Quarter 2024 Earnings: Beats Expectations
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Treace Medical Concepts Analyst Ratings
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
12 Health Care Stocks Moving In Wednesday's Intraday Session
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch
BTIG Maintains Treace Medical Concepts(TMCI.US) With Hold Rating
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Raises Target Price to $7
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Fresenius Medical Care (FMS) and Treace Medical Concepts (TMCI)
Treace Medical Concepts (TMCI) Gets a Hold From BTIG
Express News | Treace Medical Concepts Inc : Truist Securities Raises Target Price to $7 From $6
Treace Medical Concepts, Inc. (TMCI) Q3 2024 Earnings Call Transcript Summary
Express News | Treace Medical Concepts Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Raised Its FY24 Sales Guidance
Treace Medical Concepts: Q3 Earnings Snapshot